Analyst consensus rating
Cellebrite DI Analyst Rating: Strong Buy
CLBT is rated Strong Buy by 7 analysts with a $15.36 target. As of 2026-08-30.
Direct answer
Cellebrite DI's consensus rating is Strong Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $15.36.
Forecast evidence checked August 30, 2026.
Get free Cellebrite DI email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $11.99
- Average price target
- $15.36
- High price target
- $20.00
- Low price target
- $12.50
- Low target gap
- +4.3%
- Target upside
- +28.1%
- High target gap
- +66.8%
- Target range width
- 62.6%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- August 30, 2026
- Valid through
- September 6, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Cellebrite DI?
Cellebrite DI has a verified Strong Buy consensus. The same dataset has an average price target of $15.36.
How far are Cellebrite DI's low and high targets from the recorded price?
The low target implies +4.3%, while the high target implies +66.8%.
How many analysts are included in Cellebrite DI's consensus?
The verified consensus includes 7 analysts.
How is Cellebrite DI's target upside or downside calculated?
The average target of $15.36 is divided by the recorded price of $11.99, then one is subtracted to produce +28.1%. This does not guarantee a future return.
When was Cellebrite DI's analyst forecast verified?
The data was verified on 2026-08-30. The dataset is valid through 2026-09-06.